Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Listen in for real-world perspectives on the latest challenges and advancements in gastroenterology in Canada.
This series is part of Canadian IBD Today [https://canadianibdtoday.com/], an open access scientific journal for the gastroenterology community.
All content for Science for the Real World: Canadian IBD Today is the property of Catalytic Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Listen in for real-world perspectives on the latest challenges and advancements in gastroenterology in Canada.
This series is part of Canadian IBD Today [https://canadianibdtoday.com/], an open access scientific journal for the gastroenterology community.
Dr. Chris Ma speaks with Dr. Brian Feagan and Dr. Allen Lim about the role of IL-23 inhibitors in the management of Crohn's disease.
This episode of Science for the Real World is part of Canadian IBD Today [https://canadianibdtoday.com/], an open access scientific journal for the gastroenterology community.
Science for the Real World: Canadian IBD Today
Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Listen in for real-world perspectives on the latest challenges and advancements in gastroenterology in Canada.
This series is part of Canadian IBD Today [https://canadianibdtoday.com/], an open access scientific journal for the gastroenterology community.
